Advanced Search

 

Study ID Status Title Patient Level Data
117276 Completed Immunogenicity and safety study of GSK Biologicals’ Quadrivalent Split Virion Influenza Vaccine 2014/2015 Influsplit™ Tetra (Fluarix™ Tetra) (GSK2321138A) when co-administered with Pneumovax™ 23 in adults 50 years of age and older Study Listed on ClinicalStudyDataRequest.com
117277 Active, not recruiting BRF117277: A Phase II, Open-Label, Multicentre Study of Dabrafenib plus Trametinib in Subjects with BRAF Mutation-Positive Melanoma that has Metastasized to the Brain
117283 Completed Study of Losmapimod to Reduce Proteinuria in Idiopathic Focal Segmental Glomerulosclerosis (FSGS)
117285 Not yet recruiting Prevalence and characteristic of bipolar disorders and major depression in patients with a major depressive episode in Japan.
117287 Terminated A randomised open label placebo controlled study to evaluate fractional collagen synthesis in keloids and identify biomarkers of keloid biology for potential application in future clinical trials
117291 Completed A randomized, open-label, comparative study to evaluate an intermittent dosing regimen of fluticasone propionate 0.05% cream (twice per week) in reducing the risk of relapse when added to regular daily moisturization using PHYSIOGEL Lotion in paediatric subjects with stabilized atopic dermatitis
117295 Completed Evaluation of use of belimumab in clinical practice settings
117300 Completed EVALUATION OF USE OF BELIMUMAB IN CLINICAL PRACTICE SETTINGS (OBSERVE): OBSERVATIONS FROM CANADA
117307 Withdrawn Long-term hepatitis A and B antibody persistence in healthy adult subjects, primed 16 to 20 years earlier with GSK Biologicals’ combined hepatitis A and B vaccine, Twinrix® (SB208127) in study HAB-084 (208127/084)
117313 Completed A Single Center, Randomized, Open-Label, Sequential, Single Dose, 4-Period Crossover Study to Evaluate the Bioavailability and Food Effect of a Gelatin Formulation and Two Prototype Formulations of Afuresertib, an AKT Inhibitor, in Normal Healthy Volunteers
117314 Recruiting A Randomised, Multicentre, Open Label, Phase II Study of Prophylactic Octreotide to Prevent or Reduce the Frequency and Severity of Diarrhoea in Subjects Receiving Lapatinib With Capecitabine for the Treatment of Metastatic Breast Cancer
117326 Completed A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of 160 mg Enteric-coated Micronised Free Base Darapladib in Healthy Chinese Subjects. Study Listed on ClinicalStudyDataRequest.com
117342 Completed An Evaluation of the Bioequivalence of five 0.1 mg GI198745/dutasteride Soft Gelatin Capsules Compared to one 0.5 mg GI198745/dutasteride Gelatin Capsules in Healthy Male Volunteers Study Listed on ClinicalStudyDataRequest.com
117347 Active, Not Recruiting META REGRESSION ANALYSIS TO INDIRECTLY COMPARE ELTROMBOPAG TO ROMIPLOSTIM FOR THE TREATMENT OF IDIOPATHIC THROMBOCYTOPENIA
117348 Active, Not Recruiting PAZOPANIB FOR THE FIRST AND SECOND LINE TREATMENT OF ADVANCED STAGE PATIENTS WITH GOOD TO INTERMEDIATE RISK RENAL CELL CARCINOMIA: A COST MINIMIZATION ANALYSIS
117349 Completed A Single-Center, Three-Part, Open Label Study to Evaluate the Relative Bioavailability of Two Formulations, Food Effect, and Interaction with Itraconazole Following Single Dose of GSK2140944 in Healthy Subjects and Effect of Food on Safety, Tolerability, and Pharmacokinetics Following Multiple Doses of GSK2140944 in Healthy Elderly Subjects Study Listed on ClinicalStudyDataRequest.com
117351 Completed A Phase I, Multi-Center, Open-Label, Single-Dose, 2 Part Study to Evaluate the Relative Bioavailability of Three Formulations in Healthy Subjects, Food Effect on Tablet Formulation in Healthy Subjects, and Pharmacokinetics of Gepotidacin (GSK2140944) in Japanese and Chinese Subjects
117360 Completed Multi-arm, Non-randomized, Open-Label Phase IB Study to Evaluate GSK3052230 in Combination with paclitaxel and carboplatin, or docetaxel or as Single Agent in Subjects with Solid Malignancies and Deregulated FGF Pathway Signaling
117365 Completed PGx6652: Genetic Evaluation of Pazopanib –Related Hepatotoxicity
117366 Recruiting An extension study of eltrombopag in pediatric patients with chronic immune (idiopathic) thrombocytopenia purpura (ITP)
117374 Active, Not Recruiting PGx6633: FLAIR (GSK2190915) ADME Replication, Exploring the roles of UGT1A1 and UGT1A3
117375 Active, Not Recruiting HO-12-9141 SLS in-depth exit interviews on patient centered outcomes in COPD and asthma
117380 Completed A Phase I, Open-Label, Parallel-Group, Two-Part Study to Evaluate the Pharmacokinetics and Safety of GSK2336805 in Subjects with Hepatic Impairment and Healthy Matched Control Subjects (HAI117380)
117385 Active, Not Recruiting Adjusting for treatment crossover in the BREAK-3 and METRIC trials
117387 Completed A Sponsor un-blinded, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Repeat, Ascending Doses of GSK2798745 in Healthy Subjects and Stable Heart Failure Patients

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.